iBio, Inc. (IBIO)

NASDAQ: IBIO · Real-Time Price · USD

0.7290

+0.1559 (27.20%)

At close: Aug 13, 2025, 4:00 PM

0.7400

+0.0110 (1.51%)

After-hours: Aug 13, 2025, 7:57 PM EDT

Revenue by Product

Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2022	FY 2021	FY 2020	FY 2019	2017 - 2019
Period Ending	Jun '24 Jun 30, 2024	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	2017 - 2019
Precision Antibodies	225.00K	Log In	Log In	Log In	Log In	Upgrade
Biopharmaceuticals (iBio Inc.)	-	Log In	Log In	Log In	Log In	Upgrade
Biopharmaceuticals (iBio Inc.) Growth	-	Log In	Log In	Log In	Log In	Upgrade
Bioprocessing (iBio CDMO)	-	Log In	Log In	Log In	Log In	Upgrade
Bioprocessing (iBio CDMO) Growth	-	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2022	FY 2021	FY 2020	FY 2019	2017 - 2019
Period Ending	Jun '24 Jun 30, 2024	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	2017 - 2019
United States	225.00K	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-90.56%	Log In	Log In	Log In	Log In	Upgrade